Spero Therapeutics, Inc. (NASDAQ:SPRO) Long Term Shareholder Notice: Investigation over Possible Wrongdoing Announced
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Spero Therapeutics, Inc.
View full press release